Antimicrob Agents Chemother 32(4): 426-429
Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.
Abstract
Uncomplicated urogenital and concomitant oropharyngeal gonorrhea in 424 male and female patients was treated in a randomized comparative study with 0.5 g of cefodizime (89 men and 54 women), 1 g of cefodizime (87 men and 52 women), or 1 g of cefotaxime (86 men and 56 women). The cure rates were 100% for men and women in the group given 0.5 g of cefodizime, 100% for men and women in the group given 1 g of cefodizime, and 99% for men and 100% for women in the group given 1 g of cefotaxime. The MICs of cefodizime and cefotaxime for the isolate of Neisseria gonorrhoeae ranged from 0.004 to 0.06 micrograms/ml. Chlamydia trachomatis was isolated before treatment in 15% and after treatment in 13% of all patients. Side effects, such as nausea, diarrhea, abdominal pain, genital candidiasis, and pain at the site of injection, developed in 4% of the patients given cefodizime. Side effects, such as vertigo, genital candidiasis, fatigability, and diarrhea, developed in 4% of the patients treated with cefotaxime. In both groups of patients, the side effects were mild and transient. Cefodizime and cefotaxime are safe and effective agents in the treatment of uncomplicated urogenital gonorrhea.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (764K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aardoom HA, de Hoop D, Iserief CO, Michel MF, Stolz E. Detection of Neisseria gonorrhoeae antigen by a solid-phase enzyme immunoassay. Br J Vener Dis. 1982 Dec;58(6):359–362.[PMC free article] [PubMed] [Google Scholar]
- Ansink-Schipper MC, Huikeshoven MH, Woudstra RK, van Klingeren B, de Koning GA, Tio D, Schoonhoven FJ, Coutinho RA. Epidemiology of PPNG infections in Amsterdam: analysis by auxanographic typing and plasmid characterisation. Br J Vener Dis. 1984 Feb;60(1):23–28.[PMC free article] [PubMed] [Google Scholar]
- Khan MY, Gruninger RP, Nelson SM, Obaid SR. Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1983 Mar;23(3):477–478.[PMC free article] [PubMed] [Google Scholar]
- O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288.[PMC free article] [PubMed] [Google Scholar]
- Schalla WO, Whittington WL, Rice RJ, Larsen SA. Epidemiological characterization of Neisseria gonorrhoeae by lectins. J Clin Microbiol. 1985 Sep;22(3):379–382.[PMC free article] [PubMed] [Google Scholar]
- Scully BE, Jules K, Neu HC. In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin. Antimicrob Agents Chemother. 1983 Jun;23(6):907–913.[PMC free article] [PubMed] [Google Scholar]
- Stamm WE, Tam M, Koester M, Cles L. Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol. 1983 Apr;17(4):666–668.[PMC free article] [PubMed] [Google Scholar]
- Stolz E, Ong L, van Joost T, Michel MF. Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g. J Antimicrob Chemother. 1984 Sep;14 (Suppl B):295–299. [PubMed] [Google Scholar]
- Stolz E, Zwart HG, Michel MF. Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam. Br J Vener Dis. 1974 Jun;50(3):202–207.[PMC free article] [PubMed] [Google Scholar]
- Tegelberg-Stassen MJ, van der Hoek JC, Mooi L, Wagenvoort JH, van Joost T, Michel MF, Stolz E. Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. Eur J Clin Microbiol. 1986 Apr;5(2):244–246. [PubMed] [Google Scholar]
- Tegelberg-Stassen MJ, van der Willigen AH, van der Hoek JC, Wagenvoort JH, van Vliet HJ, van Klingeren B, van Joost T, Michel MF, Stolz E. Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin. Eur J Clin Microbiol. 1986 Aug;5(4):395–398. [PubMed] [Google Scholar]
- van der Willigen AH, van der Hoek JC, Wagenvoort JH, van Vliet HJ, van Klingeren B, Schalla WO, Knapp JS, van Joost T, Michel MF, Stolz E. Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother. 1987 Apr;31(4):535–538.[PMC free article] [PubMed] [Google Scholar]